Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Signant Health

Health Tech & Medtech · Whitpain Township, United States · Founded 2000 Unicorn

Leading provider of patient-centric technology solutions for the assessment of clinical trial outcomes

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
2–5k
Current team size
Unlock exact value
Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

5 investors on Signant Health's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Stratos Ventures
Series B+ 4 investors entered at this stage
Nordic Venture Partners
3i Group
Smac Partners
CPP Investments

Global footprint

Where Signant Health has talent and traffic

AI talent share
0.3% of workforce is AI talent
(7 of 2,055 staff)
Core AI00%
Other AI70.34%
Non-AI workforce2,04899.66%
Workforce by country
32 countries with
team presence
🇷🇴 Romania28.3%
🇺🇸 United States27.5%
🇮🇳 India15.3%
🇬🇧 United Kingdom6.9%
🇫🇮 Finland5.3%
Top 5 of 32 shown
Web traffic by country
92K monthly visits
across markets
🇺🇸 United States31.1%
🇯🇵 Japan30%
🇨🇦 Canada6.5%
🇷🇴 Romania6.3%
🇨🇱 Chile5%
Top 5 markets shown

Patent intelligence

$3M patent portfolio · 10 active families

Estimated portfolio value
$3M
0.28% of valuation · comparable to top peer Health Catalyst ($3M)
10 active patent families
Where Signant Health innovates Clinical testsHuman–computer interactionUser interfaceClinical trialMicrophone

Where Signant Health concentrates vs peers

Each axis is a top-10 topic across Signant Health and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Signant Health's 3 investments and acquisitions.

Every disclosed deal where Signant Health appeared as a backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Signant Health's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Signant Health deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Signant Health's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Signant Health

        An AI-synthesized read of the highest-engagement posts about Signant Health on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Signant Health on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles